Evidence map›Paper›PMID 39967861›Full record

ReviewFrontiers in transplantation2025

Immunomodulation by allograft endothelial cells.

Sayantan Bose, Vicki Do, Chiara Testini, Suchita S Jadhav, Nicolas Sailliet, Alvin T Kho, Masaki Komatsu, Leo Boneschansker, Sek Won Kong, Johannes Wedel and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sayantan BoseTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Vicki DoTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Chiara TestiniTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Suchita S JadhavTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Nicolas SaillietTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Alvin T KhoTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Masaki KomatsuTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Leo BoneschanskerTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Sek Won KongTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Johannes WedelTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.
David M BriscoeTransplant Research Program, Boston Children's Hospital, Boston, MA, United States.

Funding

Advancing Transplantation Outcomes in ChildrenU01AI163072 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI David M. Briscoe · 2021 to 2026
$15.3M
Role of DEPTOR in T Cell Activation and AlloimmunityR01AI136503 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2018 to 2022
$3.1M
Neuropilin-2 in AlloimmunityR01AI148539 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2020 to 2024
$2.5M
NIAID NIH HHS R01 AI136503NIAID NIH HHS R01 AI148539NIAID NIH HHS U01 AI163072
6 · The paper itself

Abstract

It is increasingly appreciated that the expression of immunoregulatory molecules within tumors have potential to shape a microenvironment that promotes local immunoevasion and immunoregulation. However, little is known about tissue-intrinsic immunomodulatory mechanisms following transplantation. We propose that differences in the phenotype of microvascular endothelial cells impact the alloantigenicity of the graft and its potential to promote immunoregulation following transplantation. We focus this review on the concept that graft-dependent immunoregulation may evolve post-transplantation, and that it is dependent on the phenotype of select subsets of intragraft endothelial cells. We also discuss evidence that long-term graft survival is critically dependent on adaptive interactions among immune cells and endothelial cells within the transplanted tissue microenvironment.

Indexed as

allograft (ALLO)endothelial cellgraft survivalimmunoregulationtransplantation

Identifiers

PMID39967861
PMCPMC11832486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.